Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Slavin, M. A.
Right arrow Articles by the Australian Mycology Interest Group,
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Slavin, M. A.
Right arrow Articles by the Australian Mycology Interest Group,
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2002) 49, 3-6
© 2002 The British Society for Antimicrobial Chemotherapy


Supplement

The epidemiology of candidaemia and mould infections in Australia

Monica A. Slavin,* and the Australian Mycology Interest Group,{dagger}

Department of Infectious Diseases, The Royal Melbourne Hospital, Gratton Street, Parkville, VIC 3050, Melbourne, Australia

Abstract

A retrospective review of Candida bloodstream infections (BSI) in Australian hospitals between 1995 and 1998 was performed. Nine tertiary referral hospitals in the States of New South Wales, Victoria, South Australia and Queensland participated. Of all isolates, 56% were Candida albicans, 14% Candida parapsilosis, 13% Candida glabrata, 5% Candida krusei and 4.5% Candida tropicalis. There were significant differences in the distribution of species in different patient groups. Among surgical patients, 69% of candidaemia was due to C. albicans, whereas among medical patients the proportion was 52%, and in haematology patients 43% (P = 0.0012; Pearson {chi}2). BSI with C. krusei were almost exclusive to haematology patients and were the second leading cause of Candida infection in that group, accounting for 27% of infections. The temporal pattern of Candida isolates also revealed a relationship between the latter years of the study and a lower likelihood of infection with C. albicans. Logistic regression showed year of the study [P = 0.032; odds ratio (OR) 0.81; 95% confidence interval (CI) 0.67–0.98] and surgery (P = 0.005; OR 2.02; 95% CI 1.2–3.1) to be significant variables. The rate of candidaemia in Australian hospitals was similar to that reported for US hospitals at 0.1–0.27 per 1000 discharges. Since April 1998, the clinical database on the internet resource Mycology Online has invited submission of clinical details from cases of invasive mycoses from Australian clinicians. To date, descriptions of 43 patients with proven or presumptive mould infection have been entered on the database. Of these, the leading cause was infection with Aspergillus (n = 16), followed by Zygomycetes (n = 7), Fusarium (n = 5), Scedosporium (n = 5) and Exserohilum (n = 1). Although Aspergillus infections were the most frequent on the database, the variety of mould infections seen in this short time was surprising. A knowledge of local patterns of infection and antifungal susceptibility is useful in selecting empirical therapy and formulating prophylactic and pre-emptive strategies.

Notes

* Tel: 61-3-9342-7212; Fax: 61-3-9342-7277; E-mail: monica.slavin{at}mh.org.au

{dagger} Members of the Australian Mycology Interest Group are listed in the Acknowledgements.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
J. T. Magee, M. L. Heginbothom, and B. W. Mason
Finding a strategy: the case for co-operative research on resistance epidemiology
J. Antimicrob. Chemother., May 1, 2005; 55(5): 628 - 633.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. L. Heginbothom, J. T. Magee, J. L. Bell, F. D. J. Dunstan, A. J. Howard, S. L. Hillier, S. R. Palmer, B. W. Mason, and on behalf of the Welsh Antibiotic Study Group
Laboratory testing policies and their effects on routine surveillance of community antimicrobial resistance
J. Antimicrob. Chemother., June 1, 2004; 53(6): 1010 - 1017.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
R. Reynolds, J. Shackcloth, D. Felmingham, A. MacGowan, and on behalf of the BSAC Extended Working Party on Re
Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme
J. Antimicrob. Chemother., December 1, 2003; 52(6): 931 - 943.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
M. A. Pfaller, D. J. Diekema, S. A. Messer, L. Boyken, and R. J. Hollis
Activities of Fluconazole and Voriconazole against 1,586 Recent Clinical Isolates of Candida Species Determined by Broth Microdilution, Disk Diffusion, and Etest Methods: Report from The ARTEMIS Global Antifungal Susceptibility Program, 2001
J. Clin. Microbiol., April 1, 2003; 41(4): 1440 - 1446.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.